CMS is hosting a November 14, 2016 “listening session” to obtain stakeholder input on implementation of section 704 of the Comprehensive Addiction and Recovery Act of 2016 (CARA), Under this provision, Medicare Part D sponsors may establish drug management programs for at-risk beneficiaries to limit access to frequently-abused drugs to certain prescribers and pharmacies.

The Senate has overwhelmingly approved S. 524, the Comprehensive Addiction and Recovery Act, which includes a number of provisions to prevent drug abuse, treat addiction, and reduce overdose deaths. Major provisions include: additional prevention and education efforts to prevent opioid and heroin abuse; expanded law enforcement and first responder access to the overdose-reversal drug